Texas Bank & Trust Co purchased a new stake in shares of Aflac Incorporated (NYSE:AFL - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 9,554 shares of the financial services provider's stock, valued at approximately $988,000.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in AFL. Private Trust Co. NA grew its holdings in shares of Aflac by 1.3% during the 4th quarter. Private Trust Co. NA now owns 7,643 shares of the financial services provider's stock worth $791,000 after purchasing an additional 99 shares during the period. Phillips Wealth Planners LLC lifted its position in Aflac by 1.5% during the fourth quarter. Phillips Wealth Planners LLC now owns 6,553 shares of the financial services provider's stock valued at $662,000 after buying an additional 100 shares in the last quarter. Raleigh Capital Management Inc. grew its stake in Aflac by 23.2% during the fourth quarter. Raleigh Capital Management Inc. now owns 531 shares of the financial services provider's stock worth $55,000 after buying an additional 100 shares during the period. TKG Advisors LLC increased its position in shares of Aflac by 0.5% in the fourth quarter. TKG Advisors LLC now owns 21,255 shares of the financial services provider's stock worth $2,230,000 after acquiring an additional 103 shares in the last quarter. Finally, Robertson Stephens Wealth Management LLC raised its stake in shares of Aflac by 1.6% in the 4th quarter. Robertson Stephens Wealth Management LLC now owns 6,960 shares of the financial services provider's stock valued at $720,000 after acquiring an additional 107 shares during the period. 67.44% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at Aflac
In related news, Director Arthur Reginald Collins sold 2,750 shares of the firm's stock in a transaction on Thursday, May 15th. The stock was sold at an average price of $105.70, for a total transaction of $290,675.00. Following the transaction, the director now directly owns 6,728 shares in the company, valued at $711,149.60. This trade represents a 29.01% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Joseph L. Moskowitz sold 1,000 shares of the business's stock in a transaction on Friday, March 7th. The shares were sold at an average price of $107.63, for a total transaction of $107,630.00. Following the sale, the director now owns 25,393 shares of the company's stock, valued at approximately $2,733,048.59. The trade was a 3.79% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 71,552 shares of company stock valued at $7,609,382 over the last three months. 0.90% of the stock is owned by insiders.
Aflac Stock Up 0.2%
Shares of Aflac stock traded up $0.16 on Friday, hitting $102.61. 496,231 shares of the company's stock traded hands, compared to its average volume of 2,109,008. Aflac Incorporated has a 52-week low of $86.46 and a 52-week high of $115.50. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. The stock has a market cap of $55.48 billion, a P/E ratio of 10.68, a PEG ratio of 3.24 and a beta of 0.84. The firm's 50-day moving average is $106.85 and its 200 day moving average is $106.44.
Aflac (NYSE:AFL - Get Free Report) last posted its quarterly earnings data on Wednesday, April 30th. The financial services provider reported $1.66 EPS for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). The company had revenue of $3.40 billion for the quarter, compared to the consensus estimate of $4.53 billion. Aflac had a net margin of 28.76% and a return on equity of 16.20%. The company's revenue was down 37.5% compared to the same quarter last year. During the same quarter last year, the company earned $1.66 earnings per share. Equities analysts anticipate that Aflac Incorporated will post 6.88 earnings per share for the current year.
Aflac Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Monday, June 2nd. Investors of record on Wednesday, May 21st will be paid a $0.58 dividend. The ex-dividend date is Wednesday, May 21st. This represents a $2.32 dividend on an annualized basis and a yield of 2.26%. Aflac's dividend payout ratio (DPR) is 36.25%.
Wall Street Analysts Forecast Growth
A number of analysts recently weighed in on AFL shares. BMO Capital Markets began coverage on shares of Aflac in a research report on Thursday, January 23rd. They set a "market perform" rating and a $111.00 price target for the company. Wells Fargo & Company upped their target price on Aflac from $102.00 to $103.00 and gave the stock an "equal weight" rating in a research report on Tuesday, May 6th. Piper Sandler raised their target price on Aflac from $118.00 to $124.00 and gave the company an "overweight" rating in a report on Wednesday, April 2nd. Keefe, Bruyette & Woods boosted their price target on Aflac from $104.00 to $106.00 and gave the stock a "market perform" rating in a research report on Wednesday, May 7th. Finally, Wall Street Zen downgraded shares of Aflac from a "hold" rating to a "sell" rating in a research report on Monday, May 5th. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat, Aflac has a consensus rating of "Hold" and an average target price of $104.57.
Check Out Our Latest Report on AFL
Aflac Profile
(
Free Report)
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Further Reading

Before you consider Aflac, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.
While Aflac currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.